We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

60 hedge funds and large institutions have $392M invested in Aerie Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 8

86% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 14

31% more capital invested

Capital invested by funds: $298M → $392M (+$93.9M)

13% more funds holding

Funds holding: 53 → 60 (+7)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
60
Holders Change
+7
Holders Change %
+13.21%
% of All Funds
1.72%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
15
Increased
26
Reduced
14
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$15.8M
2
DM
Deerfield Management
New York
+$13.6M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$9.4M
4
Goldman Sachs
Goldman Sachs
New York
+$5.36M
5
CNB
City National Bank
California
+$1.76M

Top Sellers

Rank Fund Capital Flow
1
IHM
Iguana Healthcare Management
New York
-$1.11M
2
ARC
Absolute Return Capital
Massachusetts
-$1.05M
3
IMS
Index Management Solutions
Pennsylvania
-$655K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$633K
5
Jennison Associates
Jennison Associates
New York
-$456K
Name Holding Trade Value Shares
Change 		Change in
Stake
JC
26
Jetstream Capital
Tennessee
$991K +$693K +40,000 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$956K +$98.4K +5,681 +17%
TCIM
28
TIAA CREF Investment Management
New York
$936K +$204K +11,800 +45%
Millennium Management
29
Millennium Management
New York
$897K +$627K +36,203 New
BIM
30
BlackRock Investment Management
Delaware
$747K +$132K +7,644 +34%
EI
31
EAM Investors
California
$736K +$515K +29,730 New
NFA
32
Nationwide Fund Advisors
Ohio
$676K +$36.3K +2,093 +8%
BA
33
BlackRock Advisors
Delaware
$660K -$106K -6,101 -19%
RFC
34
Russell Frank Company
Washington
$597K +$418K +24,110 New
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$476K +$90.1K +5,200 +37%
Charles Schwab
36
Charles Schwab
California
$397K +$83.1K +4,800 +43%
TA
37
Teachers Advisors
New York
$380K +$51.6K +2,978 +24%
TC
38
TFS Capital
Pennsylvania
$362K -$90.6K -5,229 -26%
Macquarie Group
39
Macquarie Group
Australia
$321K +$225K +12,976 New
CS
40
Credit Suisse
Switzerland
$277K -$108K -6,259 -36%
Jane Street
41
Jane Street
New York
$231K +$162K +9,338 New
Morgan Stanley
42
Morgan Stanley
New York
$212K +$61.8K +3,568 +72%
MLICM
43
Metropolitan Life Insurance Company (MetLife)
New York
$212K +$148K +8,558 New
KeyBank National Association
44
KeyBank National Association
Ohio
$210K +$147K +8,480 New
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$188K +$17.7K +1,023 +16%
AIG
46
American International Group
New York
$170K +$28K +1,618 +31%
Deutsche Bank
47
Deutsche Bank
Germany
$159K -$8K -462 -7%
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$153K -$633K -36,552 -86%
AllianceBernstein
49
AllianceBernstein
Tennessee
$84K +$58.9K +3,400 New
TRCT
50
Tower Research Capital (TRC)
New York
$52K +$36K +2,080 New
1
2
3

AERI Hedge Fund Activity: Q2 2014 in Review

60 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q2 2014, worth a combined $392M — up 31% from $298M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new AERI positions and 8 closed out — a net gain of 7 holders — while 26 added to existing stakes and 14 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $15.8M. The largest seller was Iguana Healthcare Management, cutting an estimated $1.11M.

  • 60 institutional investors held Aerie Pharmaceuticals (AERI) as of Q2 2014, up from 53 in Q1 2014.
  • Funds reported $392M of Aerie Pharmaceuticals stock for Q2 2014, up 31% quarter-over-quarter.
  • 15 funds opened new Aerie Pharmaceuticals positions in Q2 2014 and 8 closed out, a net change of +7 holders.
  • The largest Aerie Pharmaceuticals buyer in Q2 2014 was Perceptive Advisors, an estimated $15.8M added.
  • The largest Aerie Pharmaceuticals seller in Q2 2014 was Iguana Healthcare Management, an estimated $1.11M sold.

Based on aggregated 13F filings for Q2 2014.